Regencell Bioscience Holdings Ltd (RGC)
5.61
-0.37
(-6.19%)
USD |
NASDAQ |
May 08, 16:00
5.61
0.00 (0.00%)
After-Hours: 17:54
Regencell Bioscience Holdings Market Cap: 73.00M for May 8, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 07, 2024 | 77.82M |
| May 06, 2024 | 69.36M |
| May 03, 2024 | 69.36M |
| May 02, 2024 | 84.45M |
| May 01, 2024 | 68.58M |
| April 30, 2024 | 68.58M |
| April 29, 2024 | 60.51M |
| April 26, 2024 | 69.62M |
| April 25, 2024 | 69.62M |
| April 24, 2024 | 66.37M |
| April 23, 2024 | 74.17M |
| April 22, 2024 | 83.80M |
| April 19, 2024 | 72.22M |
| April 18, 2024 | 67.93M |
| April 17, 2024 | 61.65M |
| April 16, 2024 | 48.28M |
| April 15, 2024 | 48.28M |
| April 12, 2024 | 49.58M |
| April 11, 2024 | 49.45M |
| April 10, 2024 | 47.76M |
| April 09, 2024 | 49.32M |
| April 08, 2024 | 50.75M |
| April 05, 2024 | 50.75M |
| April 04, 2024 | 48.41M |
| April 03, 2024 | 50.29M |
| Date | Value |
|---|---|
| April 02, 2024 | 52.05M |
| April 01, 2024 | 50.75M |
| March 28, 2024 | 58.56M |
| March 27, 2024 | 45.15M |
| March 26, 2024 | 44.89M |
| March 25, 2024 | 48.15M |
| March 22, 2024 | 45.55M |
| March 21, 2024 | 49.97M |
| March 20, 2024 | 51.92M |
| March 19, 2024 | 52.70M |
| March 18, 2024 | 58.56M |
| March 15, 2024 | 60.18M |
| March 14, 2024 | 63.63M |
| March 13, 2024 | 73.00M |
| March 12, 2024 | 58.56M |
| March 11, 2024 | 58.56M |
| March 08, 2024 | 58.56M |
| March 07, 2024 | 64.80M |
| March 06, 2024 | 75.08M |
| March 05, 2024 | 75.08M |
| March 04, 2024 | 78.08M |
| March 01, 2024 | 85.10M |
| February 29, 2024 | 87.84M |
| February 28, 2024 | 91.87M |
| February 27, 2024 | 94.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
44.89M
Minimum
Mar 26 2024
595.80M
Maximum
Jun 15 2022
290.99M
Average
318.82M
Median
May 13 2022
Market Cap Benchmarks
| Global Pharmatech Inc | 3.542M |
| NovaBay Pharmaceuticals Inc | 2.637M |
| Palatin Technologies Inc | 33.40M |
| iBio Inc | 6.655M |
| Theriva Biologics Inc | 7.116M |
Market Cap Related Metrics
| Price | 5.61 |